Semler Scientific, Inc. (SMLR)
USD 34.06
(-8.02%)
USD 34.06
(-8.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 22.25 Million USD | 29.37% |
| 2022 | 17.2 Million USD | -11.53% |
| 2021 | 19.44 Million USD | 21.83% |
| 2020 | 15.96 Million USD | 49.06% |
| 2019 | 10.7 Million USD | 100.45% |
| 2018 | 5.34 Million USD | 726.26% |
| 2017 | -853 Thousand USD | 60.49% |
| 2016 | -2.15 Million USD | 74.36% |
| 2015 | -8.41 Million USD | -93.94% |
| 2014 | -4.34 Million USD | -104.38% |
| 2013 | -2.12 Million USD | 12.05% |
| 2012 | -2.41 Million USD | -35.75% |
| 2011 | -1.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 6.97 Million USD | 176.61% |
| 2024 Q3 | 5.06 Million USD | -5.33% |
| 2024 Q2 | 5.35 Million USD | -23.31% |
| 2023 Q2 | 7.18 Million USD | 14.77% |
| 2023 Q1 | 6.25 Million USD | 73.01% |
| 2023 FY | 22.25 Million USD | 29.37% |
| 2023 Q4 | 2.52 Million USD | -59.96% |
| 2023 Q3 | 6.29 Million USD | -12.27% |
| 2022 Q3 | 4.46 Million USD | -13.73% |
| 2022 Q4 | 3.61 Million USD | -19.05% |
| 2022 Q1 | 3.94 Million USD | 130.64% |
| 2022 FY | 17.2 Million USD | -11.53% |
| 2022 Q2 | 5.17 Million USD | 31.29% |
| 2021 Q1 | 6.01 Million USD | 0.4% |
| 2021 Q4 | 1.71 Million USD | -67.45% |
| 2021 Q2 | 6.46 Million USD | 7.39% |
| 2021 FY | 19.44 Million USD | 21.83% |
| 2021 Q3 | 5.25 Million USD | -18.73% |
| 2020 Q1 | 3.45 Million USD | 13.25% |
| 2020 Q2 | 960 Thousand USD | -72.19% |
| 2020 Q4 | 5.99 Million USD | 7.92% |
| 2020 FY | 15.96 Million USD | 49.06% |
| 2020 Q3 | 5.55 Million USD | 478.65% |
| 2019 Q3 | 3.11 Million USD | 15.44% |
| 2019 Q2 | 2.69 Million USD | 45.36% |
| 2019 Q4 | 3.04 Million USD | -2.03% |
| 2019 Q1 | 1.85 Million USD | 28.13% |
| 2019 FY | 10.7 Million USD | 100.45% |
| 2018 FY | 5.34 Million USD | 726.26% |
| 2018 Q4 | 1.44 Million USD | -6.4% |
| 2018 Q3 | 1.54 Million USD | 0.72% |
| 2018 Q2 | 1.53 Million USD | 88.81% |
| 2018 Q1 | 813 Thousand USD | 116.22% |
| 2017 Q1 | -750 Thousand USD | -628.16% |
| 2017 Q2 | -554 Thousand USD | 26.13% |
| 2017 Q3 | 76 Thousand USD | 113.72% |
| 2017 Q4 | 376 Thousand USD | 394.74% |
| 2017 FY | -853 Thousand USD | 60.49% |
| 2016 Q1 | -932 Thousand USD | 77.84% |
| 2016 FY | -2.15 Million USD | 74.36% |
| 2016 Q4 | -103 Thousand USD | 59.61% |
| 2016 Q3 | -255 Thousand USD | 70.69% |
| 2016 Q2 | -870 Thousand USD | 6.65% |
| 2015 Q4 | -4.2 Million USD | -171.01% |
| 2015 Q3 | -1.55 Million USD | -18.2% |
| 2015 FY | -8.41 Million USD | -93.94% |
| 2015 Q2 | -1.31 Million USD | 2.6% |
| 2015 Q1 | -1.34 Million USD | -14.63% |
| 2014 Q1 | -790 Thousand USD | -45.22% |
| 2014 Q3 | -1.36 Million USD | -35.48% |
| 2014 Q4 | -1.17 Million USD | 13.97% |
| 2014 FY | -4.34 Million USD | -104.38% |
| 2014 Q2 | -1 Million USD | -27.72% |
| 2013 Q4 | -544 Thousand USD | -9.46% |
| 2013 Q1 | -542 Thousand USD | -26.64% |
| 2013 FY | -2.12 Million USD | 12.05% |
| 2013 Q2 | -578 Thousand USD | -6.64% |
| 2013 Q3 | -497 Thousand USD | 14.01% |
| 2012 Q3 | -642 Thousand USD | 0.0% |
| 2012 Q4 | -428 Thousand USD | 33.33% |
| 2012 FY | -2.41 Million USD | -35.75% |
| 2011 FY | -1.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 254.975% |
| Cerus Corporation | -30.05 Million USD | 174.056% |
| OrthoPediatrics Corp. | -25.76 Million USD | 186.377% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 309.54% |
| Talis Biomedical Corporation | -66.81 Million USD | 133.31% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 228.677% |
| Inogen, Inc. | -109.38 Million USD | 120.346% |
| Spectral AI, Inc. | -12.98 Million USD | 271.411% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 135.559% |
| CVRx, Inc. | -43.1 Million USD | 151.634% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 730.839% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 279.079% |
| Orthofix Medical Inc. | -139.11 Million USD | 115.999% |
| Venus Concept Inc. | -28.3 Million USD | 178.618% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 141.193% |
| Bioventus Inc. | -81.72 Million USD | 127.233% |
| BrainsWay Ltd. | -4.92 Million USD | 551.715% |
| Envoy Medical, Inc. | -18.37 Million USD | 221.147% |
| electroCore, Inc. | -18.8 Million USD | 218.352% |
| IceCure Medical Ltd | -15.57 Million USD | 242.886% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 145.906% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 228.886% |
| MaxCyte, Inc. | -48.29 Million USD | 146.08% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 286.161% |
| Nexalin Technology, Inc. | -5.69 Million USD | 490.71% |
| PAVmed Inc | -68.79 Million USD | 132.351% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 139.347% |
| RxSight, Inc. | -50.08 Million USD | 144.436% |
| Sight Sciences, Inc. | -57.27 Million USD | 138.859% |
| SI-BONE, Inc. | -46.93 Million USD | 147.423% |
| TELA Bio, Inc. | -44.07 Million USD | 150.496% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 141.101% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 143.276% |
| LivaNova PLC | -68.49 Million USD | 132.491% |
| 908 Devices Inc. | -42.75 Million USD | 152.051% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 112.835% |
| Nemaura Medical Inc. | -9.59 Million USD | 331.948% |
| NeuroPace, Inc. | -27.17 Million USD | 181.902% |
| LENSAR, Inc. | -12.22 Million USD | 281.994% |
| Apyx Medical Corporation | -17.25 Million USD | 228.953% |
| Cutera, Inc. | -156.23 Million USD | 114.246% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 358.67% |
| BioSig Technologies, Inc. | -28.51 Million USD | 178.058% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 125.395% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 199.154% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 80.044% |
| Axonics, Inc. | -26.05 Million USD | 185.413% |
| Outset Medical, Inc. | -169.77 Million USD | 113.11% |
| IRIDEX Corporation | -10 Million USD | 322.404% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 120.387% |
| IRadimed Corporation | 20.03 Million USD | -11.083% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 369.933% |
| INVO Bioscience, Inc. | -6.76 Million USD | 428.883% |
| Telesis Bio, Inc. | -35.15 Million USD | 163.317% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -55.311% |
| Varex Imaging Corporation | 32.1 Million USD | 30.667% |
| Quipt Home Medical Corp. | 3.91 Million USD | -467.9% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 283.434% |
| Pulmonx Corporation | -61.93 Million USD | 135.934% |
| Dynatronics Corporation | -2.27 Million USD | 1079.126% |
| Modular Medical, Inc. | -17.52 Million USD | 226.967% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 252.032% |
| InMode Ltd. | 195.66 Million USD | 88.625% |
| Bruker Corporation | 436.9 Million USD | 94.906% |
| Cytosorbents Corporation | -31.2 Million USD | 171.312% |
| DexCom, Inc. | 597.7 Million USD | 96.276% |
| Align Technology, Inc. | 643.33 Million USD | 96.541% |
| Viveve Medical, Inc. | -21.55 Million USD | 203.262% |
| ZimVie Inc. | -30.93 Million USD | 171.935% |
| Movano Inc. | -29.69 Million USD | 174.961% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 179.928% |
| Nexalin Technology, Inc. | -5.69 Million USD | 490.71% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 730.839% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 109.543% |
| Profound Medical Corp. | -28.61 Million USD | 177.775% |
| Insulet Corporation | 220 Million USD | 89.884% |
| enVVeno Medical Corporation | -25.23 Million USD | 188.184% |
| Surmodics, Inc. | -5.64 Million USD | 494.26% |
| iCAD, Inc. | -7.68 Million USD | 389.452% |
| Nuwellis, Inc. | -17.63 Million USD | 226.239% |
| Biotricity, Inc. | -8.82 Million USD | 352.099% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 117.782% |
| Aethlon Medical, Inc. | -12.63 Million USD | 276.124% |
| InspireMD, Inc. | -21.14 Million USD | 205.264% |
| PAVmed Inc. | -68.79 Million USD | 132.351% |
| BIOLASE, Inc. | -17.93 Million USD | 224.079% |
| Beyond Air, Inc. | -63 Million USD | 135.324% |
| FONAR Corporation | 16.53 Million USD | -34.596% |
| AxoGen, Inc. | -21.46 Million USD | 203.7% |
| Vivani Medical, Inc. | -26.96 Million USD | 182.537% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -23.363% |
| Inari Medical, Inc. | -14.03 Million USD | 258.609% |
| UFP Technologies, Inc. | 57.66 Million USD | 61.404% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 551.66% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 452.947% |
| Tenon Medical, Inc. | -15.72 Million USD | 241.515% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 397.779% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 152.114% |
| AdaptHealth Corp. | -598.4 Million USD | 103.719% |
| Sintx Technologies, Inc. | -13.35 Million USD | 266.612% |
| NanoVibronix, Inc. | -3.43 Million USD | 747.73% |
| Quanterix Corporation | -49.7 Million USD | 144.78% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 283.434% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 5926.178% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 106.654% |
| TransMedics Group, Inc. | -28.72 Million USD | 177.474% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 194.257% |
| NeuroMetrix, Inc. | -7.15 Million USD | 411.207% |
| Hyperfine, Inc. | -48.11 Million USD | 146.256% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 134.226% |
| Biomerica, Inc. | -6.36 Million USD | 449.552% |
| Bone Biologics Corporation | -9.42 Million USD | 336.055% |
| AVITA Medical, Inc. | -40.4 Million USD | 155.086% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 315.843% |
| Silk Road Medical, Inc | -59.27 Million USD | 137.55% |